{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:04:11Z","timestamp":1787321051789,"version":"build-2736575974"},"reference-count":49,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"5","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,6]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n                  <jats:p>Multiplex-based serological surveillance is a valuable but underutilized tool to understand gaps in population-level exposure, susceptibility, and immunity to infectious diseases. Assays for which blood samples can be tested for antibodies against several pathogens simultaneously, such as multiplex bead immunoassays, can more efficiently integrate public health surveillance in low- and middle-income countries. On March 7\u20138, 2023 a group of experts representing research institutions, multilateral organizations, private industry, and country partners met to discuss experiences, identify challenges and solutions, and create a community of practice for integrated, multi-pathogen serosurveillance using multiplex bead assay technologies. Participants were divided into six working groups: 1) supply chain; 2) laboratory assays; 3) seroepidemiology; 4) data analytics; 5) sustainable implementation; and 6) use case scenarios. These working groups discussed experiences, challenges, solutions, and research needs to facilitate integrated, multi-pathogen serosurveillance for public health. Several solutions were proposed to address challenges that cut across working groups.<\/jats:p>","DOI":"10.4269\/ajtmh.24-0296","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T13:20:51Z","timestamp":1725369651000},"page":"1145-1152","source":"Crossref","is-referenced-by-count":7,"title":["Challenges and Approaches to Establishing Multi-Pathogen Serosurveillance: Findings from the 2023 Serosurveillance Summit"],"prefix":"10.4269","volume":"111","author":[{"given":"Andrea C.","family":"Carcelen","sequence":"first","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex C.","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Hegde","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jaenisch","sequence":"additional","affiliation":[{"name":"Colorado School of Public Health, Aurora, Colorado;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Chu","sequence":"additional","affiliation":[{"name":"Colorado School of Public Health, Aurora, Colorado;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Rochford","sequence":"additional","affiliation":[{"name":"Colorado School of Public Health, Aurora, Colorado;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya","family":"Kostandova","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Gurley","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Wesolowski","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Azman","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"},{"name":"Geneva University Hospitals, Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona R. M.","family":"van der Klis","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerco","family":"den Hartog","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands;"},{"name":"Laboratory of Medical Immunology, Radboud UMC, Nijmegen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Drakeley","sequence":"additional","affiliation":[{"name":"London School of Tropical Medicine and Health, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Heaney","sequence":"additional","affiliation":[{"name":"Environmental Health and Engineering Department, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy K.","family":"Winter","sequence":"additional","affiliation":[{"name":"University of Georgia, Athens, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Salje","sequence":"additional","affiliation":[{"name":"Department of Genetics, University of Cambridge, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Rodriguez-Barraquer","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Leung","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy M.","family":"Njenga","sequence":"additional","affiliation":[{"name":"Kenya Medical Research Institute (KEMRI), Nairobi, Kenya;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice Wangeci","family":"Kagucia","sequence":"additional","affiliation":[{"name":"KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kondwani C.","family":"Jambo","sequence":"additional","affiliation":[{"name":"Malawi-Liverpool-Wellcome Programme (MLW), Blantyre, Malawi;"},{"name":"Liverpool School of Tropical Medicine, Liverpool, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Wolter","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa;"},{"name":"School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richelle C.","family":"Charles","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha-Idal\u00ed","family":"Saboy\u00e1-D\u00edaz","sequence":"additional","affiliation":[{"name":"Department of Communicable Diseases Prevention, Control, and Elimination, Pan American Health Organization, Washington, District of Columbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Moss","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","series-title":"Defining Collaborative Surveillance: A Core Concept for Strengthening the Global Architecture for Health Emergency Preparedness, Response, and Resilience (HEPR)","year":"2023"},{"key":"b2","series-title":"Lancet","first-page":"1831","article-title":"Defining collaborative surveillance to improve decision making for public health emergencies and beyond","volume":"401","author":"Archer","year":"2023"},{"key":"b3","series-title":"Emerg Infect Dis","first-page":"1188","article-title":"Integrated serologic surveillance of population immunity and disease transmission","volume":"24","author":"Arnold","year":"2018"},{"key":"b4","series-title":"Lancet Infect Dis","first-page":"e75","article-title":"SeroTracker: A global SARS-CoV-2 seroprevalence dashboard","volume":"21","author":"Arora","year":"2021"},{"key":"b5","series-title":"Methods","first-page":"317","article-title":"Multiplex bead array assays: Performance evaluation and comparison of sensitivity to ELISA","volume":"38","author":"Elshal","year":"2006"},{"key":"b6","series-title":"PLOS Negl Trop Dis","first-page":"e1746","article-title":"A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: Rationale and target product profiles","volume":"6","author":"Solomon","year":"2012"},{"key":"b7","series-title":"Diagn Microbiol Infect Dis","first-page":"346","article-title":"Detection of IgG-class antibodies to measles, mumps, rubella, and varicella-zoster virus using a multiplex bead immunoassay","volume":"67","author":"Dhiman","year":"2010"},{"key":"b8","series-title":"Vaccine","first-page":"2387","article-title":"Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey","volume":"37","author":"Hayford","year":"2019"},{"key":"b9","series-title":"Clin Vaccine Immunol","first-page":"433","article-title":"Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay","volume":"16","author":"de Voer","year":"2009"},{"key":"b10","series-title":"J Clin Microbiol","first-page":"2965","article-title":"Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay","volume":"45","author":"Mahony","year":"2007"},{"key":"b11","series-title":"PLoS Negl Trop Dis","first-page":"e0007127","article-title":"Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger","volume":"13","author":"Kim","year":"2019"},{"key":"b12","series-title":"PLoS Negl Trop Dis","first-page":"e0003555","article-title":"Serology for trachoma surveillance after cessation of mass drug administration","volume":"9","author":"Martin","year":"2015"},{"key":"b13","series-title":"BMC Infect Dis","first-page":"216","article-title":"Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration","volume":"14","author":"Goodhew","year":"2014"},{"key":"b14","series-title":"PLoS Negl Trop Dis","first-page":"e0004699","article-title":"Integration of multiplex bead assays for parasitic diseases into a national, population-based serosurvey of women 15\u201339 years of age in Cambodia","volume":"10","author":"Priest","year":"2016"},{"key":"b15","series-title":"Trans R Soc Trop Med Hyg","first-page":"143","article-title":"Investigation of Chagas disease in four periurban areas in northeastern Brazil: Epidemiologic survey in man, vectors, non-human hosts and reservoirs","volume":"106","author":"Lima","year":"2012"},{"key":"b16","series-title":"Malar J","first-page":"402","article-title":"High-throughput malaria serosurveillance using a one-step multiplex bead assay","volume":"18","author":"Rogier","year":"2019"},{"key":"b17","series-title":"Am J Trop Med Hyg","first-page":"312","article-title":"Evaluation of immunoglobulin G responses to Plasmodium falciparum and Plasmodium vivax in Malian school children using multiplex bead assay","volume":"96","author":"Rogier","year":"2017"},{"key":"b18","series-title":"J Clin Microbiol","first-page":"e0234821","article-title":"Development of a bead-based multiplex assay for use in multianalyte screening and surveillance of HIV, viral hepatitis, syphilis, and herpes","volume":"60","author":"Yufenyuy","year":"2022"},{"key":"b19","series-title":"J Virol","first-page":"e0067222","article-title":"Adaptation to a multiplex bead assay and seroprevalence to Rift Valley Fever N protein: Nampula Province, Mozambique, 2013\u20132014","volume":"96","author":"Rogier","year":"2022"},{"key":"b20","series-title":"Viruses","first-page":"1299","article-title":"Spatial distribution and burden of emerging arboviruses in French Guiana","volume":"13","author":"Bailly","year":"2021"},{"key":"b21","series-title":"Am J Trop Med Hyg","first-page":"260","article-title":"Performance of SARS-CoV-2 antigens in a multiplex bead assay for integrated serological surveillance of neglected tropical and other diseases","volume":"107","author":"Gwyn","year":"2022"},{"key":"b22","series-title":"Rev Panam Salud Publica","first-page":"e53","article-title":"Lessons learned from the implementation of integrated serosurveillance of communicable diseases in the Americas","volume":"47","author":"Saboy\u00e1-D\u00edaz","year":"2023"},{"key":"b23","series-title":"Am J Trop Med Hyg","first-page":"164","article-title":"Integrated cross-sectional multiplex serosurveillance of IgG antibody responses to parasitic diseases and vaccines in coastal Kenya","volume":"102","author":"Njenga","year":"2020"},{"key":"b24","series-title":"Nat Commun","first-page":"976","article-title":"Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger","volume":"13","author":"Arzika","year":"2022"},{"key":"b25","series-title":"PLoS Med","first-page":"e1003071","article-title":"Vaccination coverage survey and seroprevalence among forcibly displaced Rohingya children, Cox\u2019s Bazar, Bangladesh, 2018: A cross-sectional study","volume":"17","author":"Feldstein","year":"2020"},{"key":"b26","series-title":"Am J Trop Med Hyg","first-page":"2031","article-title":"No serological evidence of trachoma or yaws among residents of registered camps and makeshift settlements in Cox\u2019s Bazar, Bangladesh","volume":"104","author":"Cooley","year":"2021"},{"key":"b27","year":"2020"},{"key":"b28","year":"2022"},{"key":"b29","series-title":"PLoS Negl Trop Dis","first-page":"e0010657","article-title":"Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts\u2019 meeting on serum biomarkers","volume":"16","author":"Wiens","year":"2022"},{"key":"b30","series-title":"eLife","first-page":"e42869","article-title":"Nationally-representative serostudy of dengue in Bangladesh allows generalizable disease burden estimates","volume":"8","author":"Salje","year":"2019"},{"key":"b31","series-title":"Nat Commun","first-page":"589","article-title":"Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico","volume":"13","author":"Basto-Abreu","year":"2022"},{"key":"b32","series-title":"Lancet Glob Health","first-page":"e1655","article-title":"Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: A before-and-after cross-sectional household serosurvey in four districts, 2018\u20132020","volume":"10","author":"Murhekar","year":"2022"},{"key":"b33","series-title":"PLoS Negl Trop Dis","first-page":"e0006278","article-title":"Multiplex serology for impact evaluation of bed net distribution on burden of lymphatic filariasis and four species of human malaria in northern Mozambique","volume":"12","author":"Plucinski","year":"2018"},{"key":"b34","series-title":"Am J Trop Med Hyg","first-page":"339","article-title":"Serosurveillance to monitor onchocerciasis elimination: The Ugandan experience","volume":"90","author":"Oguttu","year":"2014"},{"key":"b35","series-title":"Serosurveillance Summit Meeting Report","author":"Carcelen","year":"2023"},{"key":"b36","series-title":"Trans R Soc Trop Med Hyg","first-page":"369","article-title":"Projected costs associated with school-based screening to inform deployment of Dengvaxia: Vietnam as a case study","volume":"112","author":"Turner","year":"2018"},{"key":"b37","series-title":"Epidemics","first-page":"100645","article-title":"Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance","volume":"41","author":"Donnici","year":"2022"},{"key":"b38","series-title":"Transfus (Paris)","first-page":"1321","article-title":"How do we\u2026form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?","volume":"62","author":"Fink","year":"2022"},{"key":"b39","series-title":"Int J Parasitol","first-page":"797","article-title":"Development of a new platform for neglected tropical disease surveillance","volume":"42","author":"Lammie","year":"2012"},{"key":"b40","series-title":"Int J Infect Dis","first-page":"455","article-title":"Hepatitis-B virus infection in India: Findings from a nationally representative serosurvey, 2017\u201318","volume":"100","author":"Murhekar","year":"2020"},{"key":"b41","series-title":"Lancet Microbe","first-page":"e235","article-title":"WHO international standard for evaluation of the antibody response to COVID-19 vaccines: Call for urgent action by the scientific community","volume":"3","author":"Knezevic","year":"2022"},{"key":"b42","series-title":"Expert Rev Vaccines","first-page":"327","article-title":"Immune surveillance for vaccine-preventable diseases","volume":"19","author":"den Hartog","year":"2020"},{"key":"b43","series-title":"Vaccine","first-page":"4504","article-title":"Comparison of antibody response between boys and girls after infant and childhood vaccinations in The Netherlands","volume":"37","author":"Hoes","year":"2019"},{"key":"b44","series-title":"Lancet Infect Dis","first-page":"1737","article-title":"Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3\u2008+\u20080 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: An observational, population-level, serosurveillance study","volume":"22","author":"Swarthout","year":"2022"},{"key":"b45","series-title":"Am J Trop Med Hyg","first-page":"415","article-title":"Tetanus immunity gaps in children 5\u201314 years and men \u2265 15 years of age revealed by integrated disease serosurveillance in Kenya, Tanzania, and Mozambique","volume":"96","author":"Scobie","year":"2017"},{"key":"b46","series-title":"Proc Natl Acad Sci USA","first-page":"23174","article-title":"Fine-scale heterogeneity in Schistosoma mansoni force of infection measured through antibody response","volume":"117","author":"Arnold","year":"2020"},{"key":"b47","series-title":"J Clin Virol Plus","first-page":"100139","article-title":"Comparison of one single-antigen assay and three multi-antigen SARS-CoV-2 IgG assays in Nigeria","volume":"3","author":"Iriemenam","year":"2023"},{"key":"b48","series-title":"J Clin Microbiol","article-title":"Cross-reactivity of two SARS-CoV-2 serological assays in a setting where malaria is endemic","volume":"59","author":"Steinhardt","year":"2021"},{"key":"b49","series-title":"Nat Commun","first-page":"1360","article-title":"Non-falciparum malaria infection and IgG seroprevalence among children under 15 years in Nigeria, 2018","volume":"14","author":"Herman","year":"2023"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/111\/5\/article-p1145.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/111\/5\/article-p1145.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/111\/5\/article-p1145.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T08:45:55Z","timestamp":1730882755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/111\/5\/article-p1145.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":49,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.24-0296","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]}}}